Meena B Bansal, MD Email Meena Bansal
- PROFESSOR | Medicine, Liver Diseases
- Liver Medicine
- Hospital Affiliation
- The Mount Sinai Hospital
- Center for Advanced Medicine 212-659-8554 212-659-8554
Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Transplant Hepatology Fellowship Director, leading one of the largest transplant hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her current research interests focus on how HIV may promote hepatic inflammation and fibrosis as well as novel treatments for Non-Alcoholic Steatohepatitis (NASH). She became the Director of Translational Research in the Division of Liver Diseases in 2013 and is the principal investigator in a number of clinical trials for the treatment of Hepatitis C and NASH. Since 2015 she has also served as the Chief Medical Officer of Mount Sinai Care LLC and Deputy Chief Medical Officer for Mount Sinai Health Partners, the population health platform the entire Mount Sinai Health System. In this latter role, Dr. Bansal has the opportunity to translate findings from research/clinical trials to address population health needs in an ever-changing healthcare landscape.
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Pharmacology and Therapeutics Discovery [PTD]
AB, Harvard University
MD, Cornell University Medical College
MD, New York Presbyterian - Weill Cornell Medical Center
, The New York Hospital-Cornell Medical Center
Residency, Internal Medicine
New York Presbyterian - Weill Cornell Medical Center
Hospital of the University of Penn.
Dr. Harold and Golden Lamport Research Award
Regal Awards: Research Excellence in GI and Liver
Komarov Competition-Basic Science. Philadelphia, Pennsylvania
Awarded to GI fellow performing most outstanding basic research in all Philadelphia programs
David E. Rogers Memorial Prize
The New York Hospital-Cornell University Medical College
Awarded for most outstanding research during residency training
C. Richard Bowman Memorial Award
The New York Hospital-Cornell University Medical College
Miles and Shirley Fiterman Basic Research Award
American Gastroenterological Association
Specific Clinical/Research Interests: Role of chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis; molecular regulation of hepatic fibrosis and regeneration
Current Students: Yedidya Saiman
Postdoctoral Fellows: Ana Tuyama; Ritu Agarwal
Research Personnel: Feng Hong
Summary of Research Studies:
Brief Biosketch and Research Interests Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Hepatology Fellowship Director, leading one of the largest hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her research interests focus on the role of Matrix Metalloproteinase-2 in liver fibrosis and regeneration and Role of the chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis. The latter has great implications in understanding mechanism of HCV- and HIV/HCV-induced liver disease.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Bansal during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Boehringer Ingelheim Corporation
- Cowen and Company, LLC
- Madrigal Pharmaceuticals
Scientific Advisory Board:
- The Kinetix Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.